BI 425809
BI 425809 is a pharmaceutical drug with 15 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
14
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
15 of 15 finished
0.0%
0 ended early
0
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood
Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809
A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food
Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin
Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects
Clinical Trials (15)
A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood
Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809
A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food
Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin
Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects
A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems
A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood
A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood
A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet
Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)
Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects
A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine
This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia
A Study in Healthy Men and Women to Test Which Effects Memantine and BI 425809 Have on Each Other
A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other
All 15 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 15